PROFILE: Paula Salmikangas, chair of the Committee for Advanced Therapies at the European Medicines Agency, on handicrafts, picking berries and the very first stem cell therapy
This article was originally published in SRA
Executive Summary
The European Medicines Agency's Committee for Advanced Therapy Medicinal Products (CAT) evaluates the quality, safety and efficacy of ATMPs. Senior Finnish regulator Paula Salmikangas* has chaired the committee since February 2014. In this profile, Dr Salmikangas talks to Francesca Bruce about the pitfalls of rushing a product from bench to patient and the value to companies of talking to regulators – and of her passion for berry-picking and the musical Phantom of the Opera.